Early-life course socioeconomic factors and chronic kidney disease

Advances in Chronic Kidney Disease

Volumn 22, Issue 1, 2015, Pages 16-23

  Brophy, Patrick D ^a,b,c,d,e   Shoham, David A ^a,b,c,d,e   Charlton, Jennifer R ^a,b,c,d,e   Carmody, J Bryan ^a,b,c,d,e   Reidy, Kimberly J ^a,b,c,d,e   Harshman, Lyndsay ^a,b,c,d,e   Segar, Jeffrey ^a,b,c,d,e   Askenazi, David ^a,b,c,d,e  

^a UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Pediatrics ^*  (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Chronic kidney disease; Epidemiology; Health disparities; Life course; Socioeconomic status

Indexed keywords

ACUTE KIDNEY FAILURE; AFRICAN AMERICAN; BIRTH DEFECT; CHILDHOOD; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; COST CONTROL; DEVELOPMENTAL STAGE; END STAGE RENAL DISEASE; ENVIRONMENTAL FACTOR; FOCAL GLOMERULOSCLEROSIS; GLOMERULOSCLEROSIS; HEALTH CARE COST; HEALTH DISPARITY; HEREDITY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INDIGENOUS PEOPLE; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; KIDNEY DYSPLASIA; KIDNEY FAILURE; KIDNEY HYPOPLASIA; LOW BIRTH WEIGHT; MEDICAL RESEARCH; NEWBORN INTENSIVE CARE; OBSTRUCTIVE UROPATHY; POVERTY; PREMATURE LABOR; PREMATURITY; PROTEINURIA; REVIEW; RISK FACTOR; SOCIAL EXCLUSION; SOCIAL STATUS; SOCIOECONOMICS; URINARY TRACT MALFORMATION; ADULT; CHILD; DISEASE COURSE; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; PREGNANCY; PRENATAL EXPOSURE; RENAL INSUFFICIENCY, CHRONIC; SOCIAL CLASS; UNITED STATES;

ADULT; CHILD; DISEASE PROGRESSION; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; PREGNANCY; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84920263374     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.06.006     Document Type: Review

References (109)

1. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298(17):2038-2047.
2. 2003 Annual Data Report: Atlas of End Stage Renal Disease in the United States 2003, United States Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD.
3. Feldman H., Appel L.J., Chertow G.M., et al. The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods. J Am Soc Nephrol 2003, 14(Suppl.):S148-S153.
4. Furth S., Cole S.R., Moxey-Mims M., et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 2010, 5:1642-1648.
5. Wong C., Moxey-Mims M., Jerry-Fluker J., et al. CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 2012, 60(6):1002-1011.
6. Querfeld U. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 2010, 5(9):1642-1648.
7. ESCAPE Trial Group, Wuhl E., Trivelli A., et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009, 361:1639-1650.
8. Link B.G., Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav 1995, Spec No:80-94.
9. Lynch J., Kaplan G. Socioeconomic position. Social Epidemiology 2000, 13-35. Oxford University Press, New York, NY. L. Berkman, I. Kawachi (Eds.).
10. Shoham D.A., Vupputuri S., Kshirsagar A.V. Chronic kidney disease and life course socioeconomic status: a review. Adv Chronic Kidney Dis 2005, 12(1):56-63.
11. Zacharias J.M., Young T.K., Riediger N.D., Roulette J., Bruce S.G. Prevalence, risk factors and awareness of albuminuria on a Canadian first nation: a community-based screening study. BMC Public Health 2012, 12:290.
12. Cass A., Cunningham J., Snelling P., Wang Z., Hoy W. Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians. Soc Sci Med 2004, 58(4):767-785.
13. White S.L., McGeechan K., Jones M., et al. Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand. Am J Public Health 2008, 98(7):1306-1313.
14. Crews D.C., McClellan W.M., Shoham D.A., et al. Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants. Am J Kidney Dis 2012, 60(5):779-786.
15. McClellan W.M., Newsome B.B., McClure L.A., et al. Poverty and racial disparities in kidney disease: the REGARDS study. Am J Nephrol 2010, 32(1):38-46.
16. Volkova N., McClellan W., Klein M., et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008, 19(2):356-364.
17. Cass A., Cunningham J., Hoy W. The relationship between the incidence of end-stage renal disease and markers of socioeconomic disadvantage. N S W Public Health Bull 2002, 13(7):147-151.
18. Fored C.M., Ejerblad E., Fryzek J.P., et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant 2003, 18(1):82-88.
19. Martins D., Tareen N., Zadshir A., et al. The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2006, 47(6):965-971.
20. Merkin S.S., Coresh J., Diez Roux A.V., et al. Area socioeconomic status and progressive CKD: the Atherosclerosis risk in Communities (ARIC) Study. Am J Kidney Dis 2005, 46(2):203-213.
21. Merkin S.S., Diez Roux A.V., Coresh J., Fried L.F., Jackson S.A., Powe N.R. Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: the Cardiovascular Health Study. Soc Sci Med 2007, 65(4):809-821.
22. Patzer R.E., McClellan W.M. Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol 2012, 8(9):533-541.
23. Perneger T.V., Whelton P.K., Klag M.J. Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med 1995, 155(11):1201-1208.
24. Ward M.M. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008, 51(4):563-572.
25. Shoham D.A., Vupputuri S., Diez Roux A.V., et al. Kidney disease in life-course socioeconomic context: the Atherosclerosis risk in Communities (ARIC) Study. Am J Kidney Dis 2007, 49(2):217-226.
26. Shoham D.A., Vupputuri S., Kaufman J.S., et al. Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) Study. Soc Sci Med 2008, 67(8):1311-1320.
27. Ben-Shlomo Y., Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002, 31(2):285-293.
28. Blane D. The life course, the social gradient, and health. Social Determinants of Health 1999, 64-80. Oxford University Press, Oxford, UK. M. Marmot, R. Wilkinson (Eds.).
29. National Kidney Foundation. KDOQI (Kidney Disease Outcomes Quality Initiative) Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation (Part 4): Classification and Stratification.2013.
30. NAPRTCS, Annual Report.2011.
31. Harambat J., van Stralen K.J., Kim J.J., Tizard E.J. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012, 27(3):363-373.
32. Warady B., Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol 2007, 22(12):1999-2009.
33. Tabel Y., Haskologlu Z.S., Karakas H.M., Yakinci C. Ultrasonographic screening of newborns for congenital anomalies of the kidney and the urinary tracts. Urol J 2010, 7(3):161-167.
34. Sanna-Cherchi S., Ravani P., Corbani V., et al. Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int 2009, 76(5):528-533.
35. Horbar J., Carpenter J.H., Badger G.J., et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012, 1019-1026.
36. Hack M., Flannery D.J., Schluchter M., Cartar L., Borawski E., Klein N. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002, 129(6):149-157.
37. Greenbaum L., Muñoz A., Schneider M.F., et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol 2011, 6(1):14-21.
38. Messer L.C., Vinikoor L.C., Laraia B.A., et al. Socioeconomic domains and associations with preterm birth. Soc Sci Med 2008, 67(8):1247-1257.
39. Messer L.C., Kaufman J.S., Mendola P., Laraia B.A. Black-white preterm birth disparity: a marker of inequality. Ann Epidemiol 2008, 18(11):851-858.
40. Mason S.M., Messer L.C., Laraia B.A., Mendola P. Segregation and preterm birth: the effects of neighborhood racial composition in North Carolina. Health Place 2009, 15(1):1-9.
41. Westland R., Schreuder M.F., Bökenkamp A., Spreeuwenberg M.D., van Wijk J.A. Renal injury in children with a solitary functioning kidney-the KIMONO study. Nephrol Dial Transplant 2011, 26(5):1533-1541.
42. Spencer J., Schwaderer A., McHugh K., Vanderbrink B., Becknell B., Hains D.S. The demographics and costs of inpatient vesicoureteral reflux management in the USA. Pediatr Nephrol 2011, 26(11):1995-2001.
43. Bertoli-Avella A., Conte M.L., Punzo F., et al. ROBO2 gene variants are associated with familial vesicoureteral reflux. J Am Soc Nephrol 2008, 19(4):825-831.
44. Nishimura H., Yerkes E., Hohenfellner K., et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999, 3(1):1-10.
45. Song R., Yosypiv I. Genetics of congenital anomalies of the kidney and urinary tract. Pediatr Nephrol 2011, 26(3):353-364.
46. Paces-Fessy M., Fabre M., Lesaulnier C., Cereghini S. Hnf1b and Pax2 cooperate to control different pathways in kidney and ureter morphogenesis. Hum Mol Genet 2012, 21(14):3143-3155.
47. Reidy K., Rosenblum N. Cell and molecular biology of kidney development. Semin Nephrol 2009, 29(4):321-337.
48. Hoy W., Kincaid-Smith P., Hughson M.D., et al. CKD in aboriginal Australians. Am J Kidney Dis 2010, 56(5):983-993.
49. Hoy W., Rees M., Kile E., Mathews J.D., Wang Z. A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int 1999, 56(3):1072-1077.
50. Hoy W.E., Samuel T., Mott S.A., et al. Renal biopsy findings among indigenous Australians: a nationwide review. Kidney Int 2012, 82(12):1321-1331.
51. Reidy K., Kaskel F. Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol 2007, 22(3):350-354.
52. Mallick N. Secondary focal glomerulosclerosis not due to HIV. Nephrol Dial Transplant 2003, 18(Suppl 6):vi64-vi67.
53. Hodgin J., Rasoulpour M., Markowitz G.S., D'Agati V.D. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2009, 4(1):71-76.
54. Lackland D., Bendall H.E., Osmond C., Egan B.M., Barker D.J. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med 2000, 160(10):1472-1476.
55. Furth S., Abraham A.G., Jerry-Fluker J., et al. Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol 2011, 6(9):2132-2140.
56. Hallan S., Euser A.M., Irgens L.M., Finken M.J., Holmen J., Dekker F.W. Effect of intrauterine growth restriction on kidney function at young adult age: the Nord Trondelag Health (HUNT 2) Study. Am J Kidney Dis 2008, 51(1):10-20.
57. Zandi-Nejad K., Luyckx V.A., Brenner B.M. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006, 47(3):502-508.
58. Halevy D., Radhakrishnan J., Appel G.B. Racial and socioeconomic factors in glomerular disease. Semin Nephrol 2001, 21(4):403-410.
59. Barker D. Sir Richard Doll Lecture: developmental origins of chronic disease. Public Health 2012, 126(3):185-189.
60. Barker D., Osmond C., Forsen T.J., Kajantie E., Eriksson J.G. Maternal and social origins of hypertension. Hypertension 2007, 50(3):565-571.
61. Barker D. The developmental origins of insulin resistance. Horm Res 2005, 64(Suppl 3):2-7.
62. Barker D. Fetal origins of coronary heart disease. BMJ 1995, 311(6998):171-174.
63. Hoy W., Douglas-Denton R.N., Hughson M.D., Cass A., Johnson K., Bertram J.F. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 2003, (83):S31-S37.
64. Brenner B., Garcia D., Anderson S. Glomeruli and blood pressure. Less of one, more the other?. Am J Hypertens 1988, 1(4 Pt 1):335-347.
65. Luyckx V., Brenner B. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 2005, 97:S68-S77.
66. Brenner B., Meyer T., Hostetter T. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982, 307(11):652-659.
67. Schröder H.J. Models of fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2003, 110(Suppl 1):S29-S39.
68. Baserga M., Bares A.L., Hale M.A., et al. Uteroplacental insufficiency affects kidney VEGF expression in a model of IUGR with compensatory glomerular hypertrophy and hypertension. Early Hum Dev 2009, 85(6):361-367.
69. Baserga M., Kaur R., Hale M.A., et al. Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11beta-hydroxysteroid dehydrogenase type 2 in a sex-specific manner. Am J Physiol Regul Integr Comp Physiol 2010, 299(1):R334-R342.
70. Schreuder M., Nauta J. Prenatal programming of nephron number and blood pressure. Kidney Int 2007, 72(3):265-268.
71. Merlet-Benichou C., Gilbert T., Muffat-Joly M., Lelièvre-Pégorier M., Leroy B. Intrauterine growth retardation leads to a permanent nephron deficit in the rat. Pediatr Nephrol 1994, 8(2):175-180.
72. Schreuder M., Nyengaard J.R., Fodor M., van Wijk J.A., Delemarre-van de Waal H.A. Glomerular number and function are influenced by spontaneous and induced low birth weight in rats. J Am Soc Nephrol 2005, 16(10):2913-2919.
73. Shen Q., Xu H., Wei L.M., Chen J., Liu H.M. Intrauterine growth restriction and postnatal high-protein diet affect the kidneys in adult rats. Nutrition 2011, 27(3):364-371.
74. Plank C., Nüsken K.D., Menendez-Castro C., et al. Intrauterine growth restriction following ligation of the uterine arteries leads to more severe glomerulosclerosis after mesangioproliferative glomerulonephritis in the offspring. Am J Nephrol 2010, 32(4):287-295.
75. Pham T., MacLennan N.K., Chiu C.T., Laksana G.S., Hsu J.L., Lane R.H. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 2003, 285(5):R962-R970.
76. Woroniecki R., Gaikwad A., Susztak K. Fetal environment, epigenetics, and pediatric renal disease. Pediatr Nephrol 2011, 26(5):705-711.
77. Chevalier R. Developmental renal physiology of the low birth weight pre-term newborn. J Urol 1996, 156(2 Pt 2):714-719.
78. Engle W. Development of fetal and neonatal renal function. Semin Perinatol 1986, 10(2):113-124.
79. Hinchliffe S., Sargent P.H., Howard C.V., Chan Y.F., van Velzen D. Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and Cavalieri principle. Lab Invest 1991, 64(6):777-784.
80. Osathanondh V., Potter E. Development of human kidney as shown by microdissection III. Arch Pathol 1963, 76:290-302.
81. Winearls C., Glassock R. Classification of chronic kidney disease in the elderly: pitfalls and errors. Nephron Clin Pract 2011, 119(Suppl. 1):c2-c4.
82. Rodriguez M., Gómez A.H., Abitbol C.L., Chandar J.J., Duara S., Zilleruelo G.E. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004, 7(1):17-25.
83. Sutherland M., Gubhaju L., Moore L., et al. Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 2011, 22(7):1365-1374.
84. White S., Perkovic V., Cass A., et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 2009, 54(2):248-261.
85. Bacchetta J., Harambat J., Guy B., Putet G., Cochat P., Dubourg L. Long term renal outcome of children born preterm: a regular follow-up is needed. Arch Pediatr 2009, 16(Suppl 1):S42-S48.
86. Keijzer-Veen M., Dülger A., Dekker F.W., Nauta J., van der Heijden B.J. Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age. Pediatr Nephrol 2010, 25(3):509-516.
87. Rademacher E., Sinaiko A. Albuminuria in children. Curr Opin Nephrol Hypertens 2009, 18(3):246-251.
88. Salgado C., Jardim P.C., Teles F.B., Nunes M.C. Influence of low birth weight on microalbuminuria and blood pressure of school children. Clin Nephrol 2009, 71(4):367-374.
89. Mehta R., Kellum J.A., Shah S.V., et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11(2):R31.
90. Koralkar R., Ambalavanan N., Levitan E.B., McGwin G., Goldstein S., Askenazi D. Acute kidney injury reduces survival in very low birth weight infants. Pediatr Res 2011, 69(4):354-358.
91. Kiley J., Powers S.R., Beebe R.T. Acute renal failure: eighty cases of renal tubular necrosis. N Engl J Med 1960, 262:481-486.
92. Basile D., Donohoe D., Roethe K., Osborn J.L. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001, 281(5):F887-F899.
93. Mingeot-Leclercq M., Tulkens P. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 1999, 43(5):1003-1012.
94. Holly M., Dear J.W., Hu X., et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int 2006, 496-506.
95. Askenazi D., Koralkar R., Hundley H.E., et al. Urine biomarkers predict acute kidney injury in newborns. J Pediatr 2012, 161(2):270-275.
96. Hsu C. Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 2007, 16(3):221-226.
97. Coca S., Singanamala S., Parikh C. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012, 81(5):442-448.
98. Carey W., Talley L.I., Sehring S.A., Jaskula J.M., Mathias R.S. Outcomes of dialysis initiated during the neonatal period for treatment of end-stage renal disease: a North American Pediatric Renal Trials and Collaborative Studies Special Analysis. Pediatrics 2007, 119(2):e468-e473.
99. Wedekin M., Ehrich J.H., Offner G., Pape L. Aetiology and outcome of acute and chronic renal failure in infants. Nephrol Dial Transplant 2008, 23(5):1575-1580.
100. Mong Heip T.T., Ismaili K., Collart F., et al. Clinical characteristics and outcomes of children with stage 3-5 chronic kidney disease. Pediatr Nephrol 2010, 25(5):935-940.
101. Mammen C., Al Abbas A., Skippen P., et al. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 2012, 59(4):523-530.
102. Hidalgo G., Ng D.K., Moxey-Mims M., et al. Association of income level with kidney disease severity and progression among children and adolescents with CKD: a report from the Chronic Kidney Disease in Children (CKiD) Study. Am J Kidney Dis 2013, 62(6):1087-1094.
103. Marciano R., Soares C.M., Diniz J.S., et al. Mental disorders and quality of life in pediatric patients with chronic kidney disease. J Bras Nefrol 2010, 32(3):309-315.
104. Soliday E., Kool E., Lande M.B. Psychosocial adjustment in children with kidney disease. J Pediatric Psychol 2000, 25(2):93-103.
105. Beeman S.C., Zhang M., Gubhaju L., et al. Measuring glomerular number and size in perfused kidneys using MRI. Am J Physiol Renal Physiol 2011, 300(6):F1454-F1457.
106. Paneth N.S. The problem of low birth weight. Future Child 1995, 5(1):19-34.
107. Ludwig J., Phillips D.A. Long-term effects of head start on low-income children. Ann N Y Acad Sci 2008, 1136:257-268.
108. Oyana T.J., Margai F.M. Geographic analysis of health risks of pediatric lead exposure: a golden opportunity to promote healthy neighborhoods. Arch Environ Occup Health 2007, 62(2):93-104.
109. Carmody J.B., Charlton J.R. Short-term gestation, long-term risk: Prematurity and Chronic Kidney Disease. Pediatrics 2013, 131(6):1168-1179.